Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125390341 | 12539034 | 1 | I | 20160705 | 20160708 | 20160708 | EXP | CA-BAUSCH-BL-2016-016015 | BAUSCH AND LOMB | 20.00 | YR | M | Y | 0.00000 | 20160708 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125390341 | 12539034 | 1 | PS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | Oral | U | 21515 | 150 | MG | TABLET | |||||||
125390341 | 12539034 | 2 | SS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | U | 21515 | |||||||||||
125390341 | 12539034 | 3 | C | CIPRALEX | ESCITALOPRAM OXALATE | 1 | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125390341 | 12539034 | 1 | Depression |
125390341 | 12539034 | 2 | Anxiety |
125390341 | 12539034 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125390341 | 12539034 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125390341 | 12539034 | Malaise | |
125390341 | 12539034 | Peripheral swelling | |
125390341 | 12539034 | Serum sickness-like reaction | |
125390341 | 12539034 | Swelling | |
125390341 | 12539034 | Temporomandibular joint syndrome | |
125390341 | 12539034 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |